Cleveland Clinic-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2009

  1. Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: A randomized, blinded, phase 3 trial

    Journal of Bone and Mineral Research, Vol. 24, Núm. 1, pp. 153-161